NEUROLOGY DIVISION
CLINICAL TRIAL HISTORY

Year Sponsor Co. Indication/Disease No. of Patients
2009 BMS Alzheimer's Disease Current
BMS Alzheimer's Disease Current
Eli Lilly ADHD 4
GlaxoSmithKline Migraine/Hypertension 19
J & J Adult ADHD 3
Pfizer Alzheimer's Disease 17
Sanofi Pediatric ADHD 2
Shire ADHD 2
Wyeth Major Depressive Disorder Current
Wyeth Major Depressive Disorder Current
2008 Elan Alzheimer's 5
J&J ADHD in Adults 8
MAP Migraine 3
Minster Migraine 11
Neurogen Parkinson's, Phase I 9
Novartis Depression 9
Pfizer Generalized Anxiety Disorder 17
Shire ADHD Phase I 5
Takeda Depression 3
Takeda Depression, Open-Label Extension 1
Takeda Generalized Anxiety Disorder 12
Elan Alzheimer's Disease 3
Merck Migraine 30
Novartis ADHD 18
Pfizer Generalized Anxiety Disorder Ext 8
Shire ADHD 12
Shire ADHD Ext 10
2007 Eli Lilly  ADHD in Adults 4
Pfizer Generalized Anxiety Disorder 9
Wyeth Research Major Depressive Disorder 16
Minster Research Migraines 3
Schwarz Biosciences Migraines 7
Eli Lilly  Pediatric Depression 2
Merck & Co., Inc. Migraines 20
Shire ADHD in Adolescents, Patch Study 5
Shire ADHD in Adolescents, Patch Study Ext. 4
Shire ADHD in Children, Open-Label 7
2006 Pfizer Generalized Anxiety Disorder 15
Sanofi-Aventis  Pediatric ADHD/Insomnia 9
Sanofi-Aventis  Major Depressive Disorder 25
Wyeth Research  Major Depressive Disorder 16
Novartis Major Depressive Disorder 23
Wyeth Research  Alzheimer's Disease 3
Wyeth Research  Alzheimer's Disease Open-Label Ext. 3
Shire ADHD in Children, Patch Study 11
Shire ADHD with Symptoms of Oppositionality 5
Torrey Pines Migraine  29
Eisai Parkinson's Disease 5
Eisai Parkinson's Disease Open-Label Ext. 3
GlaxoSmithKline Menstrual Migraines 25
New River ADHD in Adults 11
New River ADHD in Adults, Open-Label Ext. 10
2005 Cephalon Generalized Anxiety Disorder  20
Schwarz Biosciences Diabetic Neuropathy Open-Label Ext. 2
Johnson & Johnson Migraine 17
Merck Migraine 12
Pozen Migraine 77
Novartis Generalized Anxiety Disorder       12
Sanofi-Synthelabo Major Depressive Disorder 25
Shire/Noven ADHD in Children & Adolescents, Patch Study 14
GlaxoSmithKline Migraine 22
Shire     Adult ADHD 11
Eli Lilly Depression 26
Cephalon Generalized Anxiety Disorder Open-Label Ext. 2
2004 Eli Lilly Pediatric ADHD 23
Eli Lilly ADHD/Dyslexia 8
Wyeth Major Depressive Disorder 27
Merck Migraine 12
Pozen Migraine 74
Pozen Migraine, Open-Label Extension 4
Eli Lilly Major Depressive Disorder 26
Shire Pediatric ADHD, Patch 14
Cephalon Generalized Anxiety Disorder 20
Shire ADHD in Adolescents 12
GlaxoSmithKline Parkinson's Disease 2
Schwarz Biosciences Diabetic Neuropathy 5
Cephalon Generalized Anxiety Disorder 2
Sanofi-Synthelabo Depression 27
Wyeth Major Depressive Disorder, Outpatient 28
Wyeth  Major Depressive Disorder, Outpatient, Open-Label 13
2004 Wyeth Alzheimer's Disease, Phase 1 2
Sanofi-Synthelabo Alzheimer's Disease 8
2003 GlaxoSmithKline Depression 18
AstraZeneca Migraine 12
Ortho McNeil Migraine 16
Merck Alzheimer's Disease 20
Wyeth Research Alzheimer's Disease 2
Sanofi Alzheimer's Disease 8
Boehringer-Ingelheim Parkinson's Disease 6
Sanofi Major Depressive Disorder 20
Novartis Mild Cognitive Impairment 18
Eli Lilly Pediatric ADHD 27
2002 Forest Alzheimer's Disease (Moderate-Severe) 13
Novartis Cerebrovascular Dementia 8
Pharmacia & Upjohn Parkinson's Extension Study 12
Pozen Migraine 40
Eli Lilly Pediatric ADHD 18
Pharmacia Corp. Generalized Anxiety Disorder 25
Forest Depression 11
2001 Janssen Alzheimer's Disease 15
Janssen Mild Cognitive Impairment  5
Forest Laboratories Generalized Anxiety Disorder 20
Glaxo Smith Kline Major Depressive Disorder with Anxiety 16
Wyeth-Ayerst Panic Disorder 6
Pfizer  Alzheimer's Disease 8
Pozen Migraine  18
R.W. Johnson Migraine  10
Eli Lilly Schizophrenia 10
Eli Lilly Pediatric Attention Deficit Hyperactivity Disorder 5
Shire  Pediatric Attention Deficit Hyperactivity Disorder 12
Shire  Adult Attention Deficit Hyperactivity Disorder 8
Forest Laboratories Alzheimer's Disease 13
Novartis Cerebral Vascular Disease 8
2001 Glaxo Smith Kline Major Depressive Disorder    8
Pfizer  Major Depressive Disorder with Somatic Symptoms 32
Sepracor Geriatric Insomnia 16
Pharmacia & Upjohn Parkinson's Disease, Extension Study 12
2000 Tap Holdings, Inc. Major Depressive Disorder 31
Wyeth-Ayerst Social Anxiety Disorder    27
Neo Therapeutics Alzheimer's Disease 16
Eli Lilly Attention Deficit Hyperactivity Disorder (Pediatric) 24
Pozen Migraine 50
Abbott Dementia (Nursing Home) 8
Wyeth-Ayerst Generalized Anxiety Disorder (Pediatric) 4
Wyeth-Ayerst Social Anxiety Disorder (Pediatric) 4
Glaxo-Wellcome  Migraine 20
Pozen Migraine 48
Pharmacia-Upjohn Major Depressive Disorder 22
Eli Lilly Generalized Anxiety Disorder   5
Pharmacia-Upjohn Major Depressive Disorder 10
R.W. Johnson Migraine 10
Bristol-myers Squibb Alzheimer's Disease (Nursing Home) 8
Pharmacia-Upjohn Parkinson Disease 12
1999 Novartis Tonic-Clonic Seizures 6
Medeva Pediatric Attention Deficit Hyperactivity Disorder 12
Novartis Mild Cognitive Impairment  18
Bristol-Myers Squibb Generalized Anxiety Disorder 12
Bristol-Myers Squibb Major Depressive Disorder  24
Pharmacia-Upjohn Early Parkinson's Disease 12
Shire Attention Deficit Hyperactivity Disorder (Pediatric) 18
Pfizer Migraine 4
Pozen Migraine 50
Novartis Diabetic Neuropathy 35
Novartis Partial Seizures 5
1998 Merck Major Depressive Disorder 20
Takeda Alzheimer's Disease 31
Bristol-Myers Squibb Generalized Anxiety Disorder 24
Glaxo-Wellcome Juvenile Myocleptic Epilepsy 12
Parke-Davis Partial Seizures 10
Bristol-Myers Squibb  Sleep Disorders  10
SmithKline Beecham Generalized Anxiety Disorder 32
SmithKline Beecham Post Traumatic Stress Disorder 6
Ortho-McNeil Trigeminal Neuralgia 10
Eisai Dementia Associated with Cerebrovascular Disease 15
Bristol-Myers Squibb Acute Stroke 9
McNeil Migraine 96
Taylor Migraine 30
1997 Protodigm, LTD Alzheimer's Disease 30
Zeneca Migraine 21
Bristol Myers Squibb Generalized Anxiety Disorder 31
Roche Parkinson's Disease 14
Novartis Partial Seizures 8
Bayer Alzheimer's Disease 5
Glaxo-Wellcome Alzheimer's Disease 14
Parke-Davis Peripheral Neuropathy 18
1995 - 1996 Parke-Davis Alzheimer's Disease 20


2007 Copyright Miami Research Associates. All Rights Reserved